Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Recommendation of “Hold” from Analysts
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the […]
More Stories
Trump Meets With Zelenskyy, Says He ‘Learned a Lot’ but His Viewpoint Is Unchanged
By Jackson Richman Former President Donald Trump met with Ukrainian President Volodymyr Zelenskyy on Sept. 27 as the GOP presidential...
Lebanon crisis: Guterres urges parties to ‘step back from the brink’
UN Secretary-General António Guterres expressed grave concern on Saturday over the dramatic escalation of events in Lebanon's capital, Beirut, over...
Bank of Communications Co., Ltd. (OTCMKTS:BCMXY) Sees Significant Drop in Short Interest
Bank of Communications Co., Ltd. (OTCMKTS:BCMXY – Get Free Report) saw a large decline in short interest in September. As...
Ukraine: UN official deplores deadly double attack on hospital
The top UN aid official in Ukraine has condemned Russian attacks in the northeastern city of Sumy on Saturday which...
CEMEX, S.A.B. de C.V. (NYSE:CX) Receives Average Rating of “Moderate Buy” from Analysts
Shares of CEMEX, S.A.B. de C.V. (NYSE:CX – Get Free Report) have been assigned an average recommendation of “Moderate Buy”...
Shell plc (NYSE:SHEL) Given Average Rating of “Moderate Buy” by Brokerages
Shell plc (NYSE:SHEL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven brokerages that...